Mayo Clinic: Preclinical Tests May Lead to New Approach to Treat CNS Lymphoma

JACKSONVILLE, Fla. — A drug recently approved for use in multiple myeloma is now being tested for its ability to fight central nervous system (CNS) lymphoma, a deadly cancer of the immune system that can affect the brain, spinal cord and fluid, and eyes. The clinical trial, now open at the three campuses of Mayo [...]
Source: Mayo Clinic Jacksonville News - Category: Hospital Management Source Type: news